Largest online gastroenterology, hepatology and endoscopy education and training resource with histology, x-ray images, videos, gastro calculators, and MCQs.
(MedPage Today) — SAN FRANCISCO -– Adding the targeted agent everolimus (Afinitor) to best supportive care in patients with advanced gastric cancer failed to significantly improve overall survival, a researcher said here.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information:
verify here.